BioCentury
ARTICLE | Company News

AstraZeneca, Serono deal

July 29, 2002 7:00 AM UTC

AZN granted SRA exclusive worldwide rights to develop and market anastrozole for ovulation induction and improvement of follicular development as a first-line therapy for infertility. SRA plans to beg...